title: Eugenol inhibits calcium currents in dental afferent neurons.
abstract: Eugenol is a topical analgesic agent widely used in the dental clinic. To elucidate the molecular mechanism underlying its analgesic action, we investigated the effect of eugenol on high-voltage-activated calcium channel (HVACC) currents in dental primary afferent neurons, and with a heterologous expression system. Dental primary afferent neurons were identified by retrograde labeling with a fluorescent dye, DiI. Eugenol inhibited HVACC currents in both capsaicin-sensitive and capsaicin-insensitive dental primary afferent neurons. The HVACC inhibition by eugenol was not blocked by capsazepine, a competitive transient receptor potential vanilloid 1 (TRPV1) antagonist. Eugenol inhibited N-type calcium currents in the cell line C2D7, stably expressing the human N-type calcium channels, where TRPV1 was not endogenously expressed. Our results suggest that the HVACC inhibition by eugenol in dental primary afferent neurons, which is not mediated by TRPV1 activation, might contribute to eugenol's analgesic effect.
  
  
  BACKGROUND
  high-voltage-activated calcium channel, HVACC; transient receptor potential vanilloid 1, TRPV1; trigeminal ganglion, TG; dorsal root ganglion, DRG; capsazepine, CZP.
authors.affiliation: Department of Physiology, College of Dentistry and Dental Research Institute, Seoul National University, Yeongeon-Dong, Korea.
authors.forename: M H
authors.initials: MH
authors.lastname: Lee
authors.forename: K-Y
authors.initials: KY
authors.lastname: Yeon
authors.forename: C-K
authors.initials: CK
authors.lastname: Park
authors.forename: H-Y
authors.initials: HY
authors.lastname: Li
authors.forename: Z
authors.initials: Z
authors.lastname: Fang
authors.forename: M S
authors.initials: MS
authors.lastname: Kim
authors.forename: S-Y
authors.initials: SY
authors.lastname: Choi
authors.forename: S J
authors.initials: SJ
authors.lastname: Lee
authors.forename: S
authors.initials: S
authors.lastname: Lee
authors.forename: K
authors.initials: K
authors.lastname: Park
authors.forename: J-H
authors.initials: JH
authors.lastname: Lee
authors.forename: J S
authors.initials: JS
authors.lastname: Kim
authors.forename: S B
authors.initials: SB
authors.lastname: Oh
mesh_terms: D000779:Anesthetics, Local / Q000494:pharmacology*; D000818:Animals; D002121:Calcium Channel Blockers / Q000494:pharmacology*; D020864:Calcium Channels, N-Type / Q000187:drug effects*; D002460:Cell Line; D003782:Dental Pulp / Q000294:innervation*; D005054:Eugenol / Q000494:pharmacology*; D006801:Humans; D008564:Membrane Potentials / Q000187:drug effects; D009475:Neurons, Afferent / Q000187:drug effects*; D009619:Nociceptors / Q000502:physiology; D051381:Rats; D011955:Receptors, Drug / Q000502:physiology; D050916:TRPV Cation Channels; D012668:Trigeminal Ganglion / Q000187:drug effects
chemical_list: D000779:Anesthetics, Local; D002121:Calcium Channel Blockers; D020864:Calcium Channels, N-Type; D011955:Receptors, Drug; D050916:TRPV Cation Channels; C494484:TRPV1 receptor; D005054:Eugenol